120 related articles for article (PubMed ID: 18226271)
1. Changes in two point discrimination and the law of mobility in diabetes mellitus patients.
Periyasamy R; Manivannan M; Narayanamurthy VBR
J Brachial Plex Peripher Nerve Inj; 2008 Jan; 3():3. PubMed ID: 18226271
[TBL] [Abstract][Full Text] [Related]
2. Vibration perception threshold and the law of mobility in diabetic mellitus patients.
Manivannan M; Periyasamy R; Narayanamurthy VB
Prim Care Diabetes; 2009 Feb; 3(1):17-21. PubMed ID: 19071079
[TBL] [Abstract][Full Text] [Related]
3. Correlation between two-point discrimination with other measures of sensory loss in diabetes mellitus patients.
Periyasamy R; Manivannan M; Narayanamurthy VB
Int J Diabetes Dev Ctries; 2008 Jul; 28(3):71-8. PubMed ID: 19902038
[TBL] [Abstract][Full Text] [Related]
4. Two-point discrimination in diabetic patients.
Eryilmaz M; Koçer A; Kocaman G; Dikici S
J Diabetes; 2013 Dec; 5(4):442-8. PubMed ID: 23560652
[TBL] [Abstract][Full Text] [Related]
5. Plantar threshold sensitivity assessment using an automated tool-Clinical assessment comparison between a control population without type 2 diabetes mellitus, and populations with type 2 diabetes mellitus, with and without neuropathy symptoms.
Castellano VK; Commander J; Burch T; Burch H; Remy J; Harman B; Zabala ME
PLoS One; 2023; 18(7):e0286559. PubMed ID: 37418442
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the accuracy of monofilament testing at various points of feet in peripheral diabetic neuropathy screening.
Baraz S; Zarea K; Shahbazian HB; Latifi SM
J Diabetes Metab Disord; 2014 Jan; 13(1):19. PubMed ID: 24472435
[TBL] [Abstract][Full Text] [Related]
7. Reversal of diabetic peripheral neuropathy and new wound incidence: the role of MIRE.
Powell MW; Carnegie DE; Burke TJ
Adv Skin Wound Care; 2004; 17(6):295-300. PubMed ID: 15289717
[TBL] [Abstract][Full Text] [Related]
8. How the impact of median neuropathy on sensorimotor control capability of hands for diabetes: an achievable assessment from functional perspectives.
Chiu HY; Hsu HY; Kuo LC; Su FC; Yu HI; Hua SC; Lu CH
PLoS One; 2014; 9(4):e94452. PubMed ID: 24722361
[TBL] [Abstract][Full Text] [Related]
9. Traditional Methods versus Quantitative Sensory Testing of the Feet at Risk: Results from the Rotterdam Diabetic Foot Study.
Rinkel WD; Castro Cabezas M; Setyo JH; Van Neck JW; Coert JH
Plast Reconstr Surg; 2017 Mar; 139(3):752e-763e. PubMed ID: 28234858
[TBL] [Abstract][Full Text] [Related]
10. Pilot study on the significance of random intrasite placement of the Semmes-Weinstein monofilament.
Slater RA; Koren S; Ramot Y; Buchs A; Rapoport MJ
Diabetes Metab Res Rev; 2013 Mar; 29(3):235-8. PubMed ID: 23283830
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Two-point Discrimination Perception in Stroke Patients with and without Diabetes Mellitus.
Kim JS; Yi SJ
J Phys Ther Sci; 2013 Aug; 25(8):1007-9. PubMed ID: 24259904
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effect of duration of diabetes mellitus on peripheral neuropathy using the United Kingdom screening test scoring system, bio-thesiometry and aesthesiometry.
Oguejiofor OC; Odenigbo CU; Oguejiofor CB
Niger J Clin Pract; 2010 Sep; 13(3):240-7. PubMed ID: 20857777
[TBL] [Abstract][Full Text] [Related]
13. Aesthesiometry: quantification of cutaneous pressure sensation in diabetic peripheral neuropathy.
Holewski JJ; Stess RM; Graf PM; Grunfeld C
J Rehabil Res Dev; 1988; 25(2):1-10. PubMed ID: 3361455
[TBL] [Abstract][Full Text] [Related]
14. [Diabetic foot risk in patients with type II diabetes mellitus in a family medicine unit].
Márquez-Godínez SA; Zonana-Nacach A; Anzaldo-Campos MC; Muñoz-Martínez JA
Semergen; 2014; 40(4):183-8. PubMed ID: 24503170
[TBL] [Abstract][Full Text] [Related]
15. Role of neuropathy and high foot pressures in diabetic foot ulceration.
Frykberg RG; Lavery LA; Pham H; Harvey C; Harkless L; Veves A
Diabetes Care; 1998 Oct; 21(10):1714-9. PubMed ID: 9773736
[TBL] [Abstract][Full Text] [Related]
16. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration.
Armstrong DG; Lavery LA; Vela SA; Quebedeaux TL; Fleischli JG
Arch Intern Med; 1998 Feb; 158(3):289-92. PubMed ID: 9472210
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic reversal of peripheral neuropathy in patients with diabetes.
Kochman AB; Carnegie DH; Burke TJ
J Am Podiatr Med Assoc; 2002 Mar; 92(3):125-30. PubMed ID: 11904323
[TBL] [Abstract][Full Text] [Related]
18. Foot screening technique in a diabetic population.
Shin JB; Seong YJ; Lee HJ; Kim SH; Park JR
J Korean Med Sci; 2000 Feb; 15(1):78-82. PubMed ID: 10719814
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Peripheral Neuropathy of Unknown Origin in an Outpatient Foot and Ankle Practice.
Klein SE; Chu J; McCormick JJ; Johnson JE
Foot Ankle Int; 2015 Sep; 36(9):1058-63. PubMed ID: 25967255
[TBL] [Abstract][Full Text] [Related]
20. Interpreting the results of the Semmes-Weinstein monofilament test: accounting for false-positive answers in the international consensus on the diabetic foot protocol by a new model.
Slater RA; Koren S; Ramot Y; Buchs A; Rapoport MJ
Diabetes Metab Res Rev; 2014 Jan; 30(1):77-80. PubMed ID: 23996640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
